Indiana · 2025 Regular Session · Bill
SB 332: Insulin price cap.
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
SB 332 is a bill introduced in the Indiana Senate on January 13, 2025. According to its official title, it concerns: Insulin price cap. Primary sponsor: Mark Spencer (Democratic). Most recent recorded action (January 13, 2025): First reading: referred to Committee on Health and Provider Services.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Requires an insurer to cap the total amount an insured is required to pay for a 30 day supply of prescription insulin drugs at an amount not to exceed $35, regardless of the number of prescriptions and different types of insulin prescribed and filled during that period.
Sponsors
Sponsors by party (alphabetical): Democratic 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Mark Spencer | Primary sponsor | Democratic | Senate | 3 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- First reading: referred to Committee on Health and Provider Services
- Authored by Senator Spencer